RadNet [RDNT] vs Qiagen N.V [QGEN] Detailed Stock Comparison
RadNet
NASDAQ
Loading...
Qiagen N.V
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: RadNet wins in 5 metrics, Qiagen N.V wins in 14 metrics, with 0 ties. Qiagen N.V appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | RadNet | Qiagen N.V | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 1,425.75 | 26.03 | Qiagen N.V |
| Price-to-Book Ratio | 6.01 | 2.72 | Qiagen N.V |
| Debt-to-Equity Ratio | 156.12 | 42.31 | Qiagen N.V |
| PEG Ratio | -2.48 | -0.17 | RadNet |
| EV/EBITDA | 30.93 | 10.08 | Qiagen N.V |
| Profit Margin (TTM) | -0.78% | 18.30% | Qiagen N.V |
| Operating Margin (TTM) | 7.12% | 25.49% | Qiagen N.V |
| EBITDA Margin (TTM) | 7.12% | 25.49% | Qiagen N.V |
| Return on Equity | 1.74% | 10.81% | Qiagen N.V |
| Return on Assets (TTM) | 1.55% | 9.01% | Qiagen N.V |
| Free Cash Flow (TTM) | $44.95M | $502.31M | Qiagen N.V |
| 1-Year Return | 14.07% | 6.13% | RadNet |
| Price-to-Sales Ratio (TTM) | 3.06 | 4.68 | RadNet |
| Enterprise Value | $7.00B | $10.06B | Qiagen N.V |
| EV/Revenue Ratio | 3.67 | 4.93 | RadNet |
| Gross Profit Margin (TTM) | 13.88% | 62.65% | Qiagen N.V |
| Revenue per Share (TTM) | $26 | $9 | RadNet |
| Earnings per Share (Diluted) | $-0.19 | $1.69 | Qiagen N.V |
| Beta (Stock Volatility) | 1.55 | 0.64 | Qiagen N.V |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
RadNet vs Qiagen N.V Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| RadNet | 0.44% | 4.27% | 11.41% | 40.75% | 49.17% | 11.66% |
| Qiagen N.V | -0.17% | 5.26% | -1.45% | -4.93% | 15.54% | 3.86% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| RadNet | 14.07% | 312.48% | 363.49% | 1,279.05% | 3,110.25% | 11,090.00% |
| Qiagen N.V | 6.13% | 8.77% | -15.53% | 71.77% | 159.63% | 235.07% |
News Based Sentiment: RadNet vs Qiagen N.V
RadNet
News based Sentiment: MIXED
RadNet demonstrated strong Q2 performance and continued strategic investments in AI and acquisitions, but significant insider selling and a mixed earnings outlook create a complex investment narrative. The combination of positive developments and cautionary signals warrants a 'mixed' sentiment and a relatively high importance score.
Qiagen N.V
News based Sentiment: POSITIVE
Qiagen demonstrated resilience in a down market, secured a key partnership expansion in Japan, received an analyst upgrade, and benefits from a strong growth forecast in the cancer biomarkers market. These factors collectively suggest a positive outlook for the company, though valuation remains fair.
Performance & Financial Health Analysis: RadNet vs Qiagen N.V
| Metric | RDNT | QGEN |
|---|---|---|
| Market Information | ||
| Market Cap | $5.96B | $9.69B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 718,540 | 1,123,284 |
| 90 Day Avg. Volume | 663,123 | 1,273,311 |
| Last Close | $78.33 | $46.24 |
| 52 Week Range | $45.00 - $93.65 | $37.63 - $51.88 |
| % from 52W High | -16.36% | -10.87% |
| All-Time High | $93.65 (Nov 11, 2024) | $60.81 (Jul 17, 2000) |
| % from All-Time High | -16.36% | -23.96% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.08% | 0.08% |
| Quarterly Earnings Growth | N/A | 0.07% |
| Financial Health | ||
| Profit Margin (TTM) | -0.01% | 0.18% |
| Operating Margin (TTM) | 0.07% | 0.25% |
| Return on Equity (TTM) | 0.02% | 0.11% |
| Debt to Equity (MRQ) | 156.12 | 42.31 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $12.42 | $16.17 |
| Cash per Share (MRQ) | $10.83 | $4.40 |
| Operating Cash Flow (TTM) | $261.76M | $675.03M |
| Levered Free Cash Flow (TTM) | $143.32M | $683.15M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | $0.00 |
Valuation & Enterprise Metrics Analysis: RadNet vs Qiagen N.V
| Metric | RDNT | QGEN |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 1,425.75 | 26.03 |
| Forward P/E | 99.60 | 19.21 |
| PEG Ratio | -2.48 | -0.17 |
| Price to Sales (TTM) | 3.06 | 4.68 |
| Price to Book (MRQ) | 6.01 | 2.72 |
| Market Capitalization | ||
| Market Capitalization | $5.96B | $9.69B |
| Enterprise Value | $7.00B | $10.06B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.67 | 4.93 |
| Enterprise to EBITDA | 30.93 | 10.08 |
| Risk & Other Metrics | ||
| Beta | 1.55 | 0.64 |
| Book Value per Share (MRQ) | $12.42 | $16.17 |
Financial Statements Comparison: RadNet vs Qiagen N.V
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | RDNT | QGEN |
|---|---|---|
| Revenue/Sales | $498.23M | $533.54M |
| Cost of Goods Sold | $429.09M | $199.25M |
| Gross Profit | $69.15M | $334.29M |
| Research & Development | N/A | $47.75M |
| Operating Income (EBIT) | $33.15M | $135.97M |
| EBITDA | $81.27M | $200.58M |
| Pre-Tax Income | $23.85M | $126.82M |
| Income Tax | $820,000 | $30.57M |
| Net Income (Profit) | $23.03M | $96.25M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | RDNT | QGEN |
|---|---|---|
| Cash & Equivalents | $717.32M | $638.76M |
| Total Current Assets | $1.02B | $1.74B |
| Total Current Liabilities | $505.40M | $516.94M |
| Long-Term Debt | $1.66B | $1.35B |
| Total Shareholders Equity | $1.14B | $3.41B |
| Retained Earnings | $-114.71M | $2.50B |
| Property, Plant & Equipment | $1.37B | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | RDNT | QGEN |
|---|---|---|
| Operating Cash Flow | $113.66M | $190.30M |
| Capital Expenditures | $-52.93M | $-43.90M |
| Free Cash Flow | $67.41M | $95.48M |
| Debt Repayment | $-7.00M | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | RDNT | QGEN |
|---|---|---|
| Shares Short | 6.43M | 6.67M |
| Short Ratio | 9.58 | 4.93 |
| Short % of Float | 0.10% | 0.05% |
| Average Daily Volume (10 Day) | 718,540 | 1,123,284 |
| Average Daily Volume (90 Day) | 663,123 | 1,273,311 |
| Shares Outstanding | 74.04M | 216.12M |
| Float Shares | 69.22M | 214.89M |
| % Held by Insiders | 0.13% | 0.02% |
| % Held by Institutions | 0.94% | 0.89% |
Dividend Analysis & Yield Comparison: RadNet vs Qiagen N.V
| Metric | RDNT | QGEN |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | $0.44 |
| 3-Year Avg Dividend Yield | N/A | 3.03% |
| 3-Year Total Dividends | N/A | $1.32 |
| Ex-Dividend Date | N/A | Jan 30, 2024 |